Peptide-specific cytotoxic T lymphocytes fail to recognize MAGE-A1+ or Her-2/neu+ tumor cell lines

被引:0
|
作者
Kayser, S
Rentzsch, C
Stumm, S
Wallwiener, D
Gückel, B
机构
[1] Univ Tubingen, Frauenklin, D-72076 Tubingen, Germany
[2] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany
关键词
tumor immunology; cytotoxic T-cells; tumor-associated antigens; MAGE-1; Her-2/neu;
D O I
10.1055/s-2003-43460
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose: The majority of tumor-associated antigens are derived from nonmutated self proteins. Little is currently understood about the existence and nature of self-reactive T cells that recognize these antigens in healthy volunteers or cancer patients. Here we try to establish culture conditions to expand Her-2/neu- and MAGE-A1-specific T cells from the blood of healthy donors. Material and Methods: Unseparated peripheral blood mononuclear cells of HLA-A*0201(+) healthy donors were stimulated using the well characterized tumorantigens Her-2/neu(369-377) and MAGE-A1(278-296) for in vitro immunization. The influence of different peptide concentrations loaded on autologous antigen-presenting cells on the phenotype and function of the established T cell lines was elucidated. After repetitive stimulations T cells were assayed for peptide specificity as well as tumor recognition in cytotoxicity tests. Results: Using in vitro immunization protocols it was possible to stimulate tumor antigen-specific cytotoxic T lymphocytes from the blood of healthy donors. This was supported by lower peptide concentrations. However, MAGE-A1(278-296)-specific T cells failed to react with a panel of HLA-A*0201(+)/MAGE-A1(+) tumor cells. Her-2/neu(369-377)-specific T cells were able to lyse HLAA*0201(+)/Her-2/neu(+) tumor cell lines after additional exogeneous peptide-loading. Conclusion: T cell responses toward peptides derived from tumor antigens can be easily generated in vitro. However, their antigen specificity did not necessarily reflect the lytic capacity towards antigen-expressing tumor cells. "Artificially" high concentrations of peptide presumably cause the expansion of low-avidity T cells which fail to respond to tumor cells with suboptimal antigen presentation. In contrast, cytotoxic T cells generated with low concentrations of peptide were demonstrated to be superior in peptide as well as in tumor recognition. Optimizing the conditions to expand self-reacting (tumor-specific) T cells in vitro is of relevance for the effectiveness of adoptive therapies.
引用
收藏
页码:1137 / 1145
页数:9
相关论文
共 50 条
  • [1] Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors
    Zaks, TZ
    Rosenberg, SA
    CANCER RESEARCH, 1998, 58 (21) : 4902 - 4908
  • [2] Trafficking of tumor peptide-specific cytotoxic T lymphocytes into the tumor microcirculation
    Ali, S
    Ahmad, M
    Lynam, J
    Rees, RC
    Brown, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (02) : 239 - 244
  • [3] Helper T cell dependent induction of HER-2/neu specific cytotoxic T lymphocytes by tumor cells, fused to allogeneic DC
    Stuhler, G
    Brossart, P
    Brugger, W
    Kanz, L
    CANCER GENE THERAPY, 1997, 4 (05) : 318 - 318
  • [4] IDENTIFICATION OF AN IMMUNODOMINANT PEPTIDE OF HER-2/NEU PROTOONCOGENE RECOGNIZED BY OVARIAN TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTE LINES
    FISK, B
    BLEVINS, TL
    WHARTON, JT
    IOANNIDES, CG
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2109 - 2117
  • [5] BREAST AND OVARIAN CANCER-SPECIFIC CYTOTOXIC T-LYMPHOCYTES RECOGNIZE THE SAME HER2/NEU-DERIVED PEPTIDE
    PEOPLES, GE
    GOEDEGEBUURE, PS
    SMITH, R
    LINEHAN, DC
    YOSHINO, I
    EBERLEIN, TJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) : 432 - 436
  • [6] Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes
    Brossart, P
    Stuhler, G
    Flad, T
    Stevanovic, S
    Rammensee, HG
    Kanz, L
    Brugger, W
    CANCER RESEARCH, 1998, 58 (04) : 732 - 736
  • [7] Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes
    Grünebach, F
    Kayser, K
    Weck, MM
    Müller, MR
    Appel, S
    Brossart, P
    CANCER GENE THERAPY, 2005, 12 (09) : 749 - 756
  • [8] Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes
    Frank Grünebach
    Katrin Kayser
    Markus M Weck
    Martin R Müller
    Silke Appel
    Peter Brossart
    Cancer Gene Therapy, 2005, 12 : 749 - 756
  • [9] Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma
    Oehlrich, N
    Devitt, G
    Linnebacher, M
    Schwitalle, Y
    Grosskinski, S
    Stevanovic, S
    Zöller, M
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (02) : 256 - 264
  • [10] CYTOTOXIC T-CELLS ISOLATED FROM OVARIAN MALIGNANT ASCITES RECOGNIZE A PEPTIDE DERIVED FROM THE HER-2/NEU PROTOONCOGENE
    IOANNIDES, CG
    FISK, B
    FAN, D
    BIDDISON, WE
    WHARTON, JT
    OBRIAN, CA
    CELLULAR IMMUNOLOGY, 1993, 151 (01) : 225 - 234